
Stem Cell Therapy for Herniated Disc in Cali, Colombia
Living with a herniated disc can affect mobility, sleep, work, exercise, and everyday activities. Patients experiencing persistent lower-back pain, stiffness, limited movement, or pain extending into the legs may explore regenerative medicine after appropriate clinical assessment and conservative treatment.
The Stem Cell Therapy for Herniated Disc in Cali, Colombia package at Stem Cells Kyron provides individualized medical evaluation for patients who may be suitable for a mesenchymal stem cell-based intervention involving affected intervertebral discs or facet joints.
Treatment planning is based on the patient's medical history, symptoms, neurological findings, MRI results, previous treatments, overall health, and clinical eligibility. The exact cellular product, dose, targeted spinal levels, and administration route are determined after medical evaluation.
-
Location: Cali, Colombia
-
Starting Price: USD 10,000
-
Suggested Length of Stay: 4 days
-
Cell Type: Umbilical cord-derived mesenchymal stem cells
-
Administration: Affected facet joints and intervertebral discs according to the approved treatment plan
-
Local Observation: Approximately 24–48 hours
-
Follow-Up: Virtual follow-up at Weeks 4, 14, 36, and 52
-
Treatment Status: Investigational regenerative medicine intervention
Important Information About Stem Cell Therapy for Herniated Disc
Intradiscal or facet joint application of mesenchymal stem cells remains under investigation. It should not be presented as a cure for herniation, guaranteed disc regeneration, nerve root decompression, or a substitute for rehabilitation, analgesia, surgery, or urgent care when indicated.
Stem Cell Therapy for Herniated Disc Cost in Colombia
The starting price for the package is USD 10,000.
The final treatment cost depends on the treatment protocol approved for the individual patient, required medical evaluations, cellular product, targeted spinal levels, administration route, monitoring requirements, and any additional medical services.
| Service | Package Details |
|---|---|
| Medical evaluation and file review | Virtual medical review |
| Imaging review | Lumbar MRI |
| Cellular product | Mesenchymal stem cells |
| Cellular source | Umbilical cord-derived |
| Cellular supplier | Stem Cells Bank |
| Administration area | Facet joints and intervertebral discs |
| Procedure setting | One operating-room session |
| Local observation | Based on clinical condition |
| Remote follow-up | Weeks 4, 14, 36, and 52 |
| Starting package price | USD 10,000 |
Flights, accommodation, meals, transfers, travel insurance, companion expenses, and other non-medical travel costs are not included unless specifically stated as part of the patient's individual package.
What Is Included in the Stem Cell Therapy Package?
-
Review of medical history, pain symptoms, neurological findings, previous treatments, lumbar MRI, and available medical studies.
-
Virtual or in-person medical consultation.
-
Clinical eligibility assessment.
-
Medical tests required by the approved treatment protocol.
-
Review of the cellular product, including its source, processing, identity, dose, administration route, and quality controls.
-
Administration of the cellular product.
-
Clinical monitoring following treatment.
-
Discharge documentation and post-treatment instructions.
-
Clinical contact information for follow-up.
-
Medical summary for the patient's healthcare team at home.
-
Virtual follow-up during the established follow-up period.
What Is Not Included in the Package?
-
International or domestic flights.
-
Passports or visa expenses.
-
Airport or local transportation.
-
Accommodation.
-
Meals.
-
Companion or caregiver expenses.
-
Travel insurance or medical evacuation.
-
Medical care provided outside Stem Cells Kyron.
-
Unplanned diagnostic tests.
-
Additional specialist consultations.
-
Extended accommodation or stay in Cali.
-
Emergency hospitalization.
-
Treatment of unexpected complications.
-
Physical therapy or long-term rehabilitation.
-
Strengthening programs.
-
Postural rehabilitation.
-
Aquatic therapy.
-
Weight-management programs.
-
Repeat procedures.
-
Changes to the original treatment protocol that are not included in the agreed package.
Who May Be Evaluated for Herniated Disc Stem Cell Therapy?
A herniated disc refers to localized displacement of disc material, but an abnormal MRI finding alone does not establish the cause of a patient's pain.
Before treatment is considered, the medical team evaluates whether symptoms are associated with discogenic pain, nerve-root irritation, facet-joint pain, spinal stenosis, spinal instability, or another musculoskeletal or medical condition.
Patients who may be considered for evaluation can include those with:
-
Axial lower-back pain or radicular pain with reasonable correlation between symptoms, physical examination findings, and MRI results.
-
Persistent symptoms despite appropriate conservative care.
-
Medical stability for the planned procedure.
-
Ability to provide informed consent.
-
Ability to follow post-treatment restrictions and rehabilitation recommendations.
-
Realistic treatment expectations.
-
Functional treatment goals.
-
Willingness to continue appropriate rehabilitation, exercise, ergonomics, and spine-specialist follow-up.
When Additional Assessment or Another Treatment May Be Needed
Stem cell therapy may not be appropriate for every patient with a herniated disc.
Additional assessment or another treatment strategy may be necessary in patients with:
-
Lower-back pain accompanied by fever.
-
Unexplained weight loss.
-
History of cancer with concerning symptoms.
-
Significant spinal trauma.
-
Unexplained clinical red flags.
-
Cauda equina syndrome.
-
New bowel or bladder dysfunction.
-
Saddle anesthesia.
-
Progressive motor weakness.
-
Active infection or bacteremia.
-
Discitis.
-
Osteomyelitis.
-
Spinal or systemic tumor.
-
Fracture.
-
Uncontrolled systemic disease.
-
Significant coagulation problems.
-
Anticoagulation that cannot be safely managed for the planned procedure.
-
Significant immunosuppression.
-
Pregnancy.
-
Relevant treatment-related allergies.
-
Disc extrusion or sequestration associated with substantial neurological compression.
-
Severe spinal stenosis.
-
Significant spinal instability.
-
Relevant spondylolisthesis.
-
Spinal deformity requiring another treatment approach.
Patients with urgent neurological symptoms should undergo appropriate emergency or surgical evaluation rather than delaying indicated care.
Medical Records Required Before Traveling to Cali
Patients should provide available medical information before traveling so the clinical team can review the case and determine whether further evaluation is appropriate.
-
Clinical history covering pain distribution, timeline, functional limitations, neurological deficits, and red flags.
-
List of medications, anticoagulants, antiplatelets, supplements, allergies, and infectious disease history.
-
History of prior lumbar surgeries, injections, nerve blocks, physical therapy, trauma, cancer, osteoporosis, infections, and systemic diseases.
-
Recent lumbar MRI with original images and formal report; dynamic X-rays, CT, or EMG when indicated.
-
Log of pain medications used, response to physical therapy or nerve blocks, and previous spine evaluations.
-
Legal representative documentation and emergency contact information.
How Mesenchymal Stem Cells Are Used in This Treatment
Mesenchymal stem cells are being studied for their potential paracrine and immunomodulatory effects in degenerative spinal conditions.
For this package, the cellular product is described as umbilical cord-derived mesenchymal stem cells.
The treatment approach may involve affected facet joints and intervertebral discs according to the patient's individual medical findings and approved treatment plan.
This regenerative medicine approach should not be interpreted as mechanically sealing an annular tear, removing a disc extrusion, decompressing a nerve root, or physically rebuilding a spinal segment.
The clinical evaluation therefore focuses on determining whether the patient's symptoms, imaging findings, and medical condition are appropriate for the proposed intervention.
Cellular Product and Treatment Details
| Treatment Area | Details |
|---|---|
| Cellular origin | Umbilical cord-derived mesenchymal stem cells |
| Manufacturing / supply | Stem Cells Bank |
| Product identity | Stem Cells Bank |
| Quality controls | Viability, sterility, endotoxins, mycoplasma, and applicable controls |
| Dose | Determined according to the treatment protocol |
| Administration | Surgical-suite procedure targeting affected facet joints and discs |
| Follow-up | Virtual follow-up from Week 4 through Week 52 |
The specific treatment protocol, targeted spinal levels, dose, administration route, and procedural plan are established according to the patient's clinical evaluation.
Stem Cell Therapy Clinical Process
-
Medical consultation before booking: Patients are encouraged to discuss the proposed treatment with their primary physician or another independent medical professional.
-
Medical record submission: Relevant medical records, imaging, previous treatment history, and current medications are reviewed by the Stem Cells Kyron medical team.
-
Clinical pre-selection: The medical team determines whether additional information, imaging, or medical testing is required.
-
Medical consultation: A virtual or in-person consultation is performed, with physical examination when necessary.
-
Treatment planning: The proposed protocol, treatment cost, procedure details, risks, alternatives, and informed-consent information are reviewed.
-
Patient decision: Patients have the opportunity to ask questions and make an informed decision before treatment.
-
Procedure and monitoring: The approved cellular product is administered according to the clinical plan, followed by observation and monitoring.
-
Discharge and follow-up: Patients receive post-treatment instructions and continue scheduled follow-up after returning home.
Treatment Timeline in Cali
| Stage | Activity | Expected Timing |
|---|---|---|
| Before travel | Medical records, pre-selection, treatment planning, and cost review | Approximately 1 week |
| Arrival in Cali | In-person assessment and required testing | Day 1 |
| Consent | Final review of treatment plan, risks, and alternatives | Before procedure |
| Intervention | Stem cell administration and monitoring | According to protocol |
| Local observation | Monitoring symptoms and clinical stability | 24–48 hours |
| Travel clearance | Medical assessment before departure | Based on recovery |
| Remote follow-up | Clinical review and progress monitoring | Weeks 4, 14, 36, and 52 |
The suggested stay in Cali is approximately 4 days. However, the actual stay can vary depending on the procedure, treatment route, post-procedure symptoms, neurological findings, and individual recovery.
Flexible travel arrangements are recommended because medical clearance to return home depends on clinical progress.
Travel Recommendations for Patients Visiting Cali
Patients traveling to Cali for treatment should plan their trip around their medical needs and expected recovery.
-
Travel with a companion when mobility is limited.
-
Consider companion support when sedation is planned.
-
Carry medications in their original containers.
-
Keep an updated medication list available.
-
Use flexible or changeable travel tickets when possible.
-
Maintain access to emergency medical care during the stay.
-
Follow medical advice regarding mobility after the procedure.
-
Maintain appropriate hydration.
-
Follow infection-prevention instructions.
-
Obtain medical clearance before flying home.
Patients should not independently stop or change pain medications, anticoagulants, antiplatelet medications, or other prescribed treatments.
Recovery After Stem Cell Therapy for a Herniated Disc
Recovery depends on the treatment route, number of treated spinal levels, the patient's underlying condition, and individual response to the procedure.
First 24–48 Hours
Patients should follow all observation, medication, mobility, and post-procedure instructions.
Urgent medical attention should be sought for symptoms including:
-
Fever.
-
Severe or progressively worsening pain.
-
New muscle weakness.
-
Loss of sensation.
-
Saddle anesthesia.
-
Urinary retention or incontinence.
-
Bowel dysfunction.
-
Difficulty breathing.
-
Significant allergic reaction.
-
Major deterioration in neurological or general condition.
First Week
Patients may be advised to:
-
Resume movement gradually as directed.
-
Follow puncture-site care instructions.
-
Monitor lower-back and leg pain.
-
Observe muscle strength and sensation.
-
Monitor temperature.
-
Report changes in bladder or bowel function.
-
Avoid heavy lifting.
-
Avoid unauthorized strenuous exercise.
After Returning Home
Patients should share relevant treatment documentation with their local spine specialist or healthcare provider and continue the agreed rehabilitation program.
Progress should be evaluated using functional changes rather than relying only on subjective pain improvement.
Follow-up may consider:
-
Pain level.
-
Functional ability.
-
Neurological status.
-
Use of pain medication.
-
Ability to resume normal activities.
-
Rehabilitation progress.
Risks and Possible Complications
Every invasive or cell-based medical intervention carries potential risks, which may vary according to the cellular product, processing method, route, dose, sedation or anesthesia, and the patient’s health status. Potential risks include pain, bruising, bleeding, phlebitis, local reaction, fever, headache, nausea, fatigue, transient inflammatory symptoms, allergic, immunological or infusion reactions, hypotension, breathing difficulty, infection, contamination, pathogen transmission if controls fail, thrombotic, vascular or respiratory events related to the product or delivery, and risks associated with the administration route, puncture, sedation or anesthesia. Other possible complications include unexpected biological effects, including unwanted cellular proliferation or behavior, lack of benefit, clinical worsening, financial loss, delayed effective care, discitis or spondylodiscitis, osteomyelitis, epidural abscess, facet-joint infection, nerve-root injury, worsening radiculopathy, motor or sensory deficits, dural puncture, headache, epidural or retroperitoneal hematoma, vascular injury, endplate damage, accelerated degeneration, severe post-procedural pain, and difficulty managing complications or completing follow-up after travel. The individual risk profile should be discussed before treatment.
Informed Consent
Before treatment, patients should receive informed-consent information explaining the proposed procedure, cellular product, administration route, potential benefits, limitations, possible complications, alternatives, and follow-up requirements.
The actual administration route should be clearly documented as part of the approved treatment plan.
Patients should have enough time to review the information, ask questions, and make a voluntary decision before proceeding.
Expected Outcomes and Treatment Monitoring
The purpose of clinical follow-up is to evaluate safety, symptoms, function, and overall progress. No specific clinical result can be guaranteed.
Treatment monitoring may include:
-
Lower-back pain.
-
Radicular or leg pain.
-
Functional ability.
-
Disability level.
-
Neurological findings.
-
Strength.
-
Sensation.
-
Walking ability.
-
Physical tolerance.
-
Pain-medication requirements.
-
Return to normal activities or work.
-
Quality of life.
Changes in symptoms should not automatically be interpreted as structural disc regeneration.
Clinical improvement can also be influenced by the natural course of the condition, spontaneous herniated-disc reabsorption, medications, physical therapy, changes in physical activity, and other factors.
Conservative treatment and surgical decompression remain important options when medically appropriate. Stem cell therapy should not delay urgent medical care or surgery when these are indicated.
Follow-Up Assessment Plan
| Follow-Up Stage | Objective | Assessment |
|---|---|---|
| Baseline | Establish symptoms and functional status | NRS/VAS pain score, Oswestry Disability Index, functional goals |
| Early follow-up | Evaluate safety and tolerability | Adverse events, fever, pain, neurological findings, infection signs |
| Intermediate follow-up | Evaluate functional progress | NRS/VAS, ODI, pain-medication use, activity level |
| Late follow-up | Evaluate persistence or absence of change | Comparison with baseline and imaging when clinically necessary |
Virtual follow-up is scheduled at Weeks 4, 14, 36, and 52.
About Stem Cells Kyron Colombia
Stem Cells Kyron Colombia SCKC is loca
ted in Cali, Colombia and focuses on regenerative medicine and cellular intervention evaluation.
| Institutional Information | Details |
|---|---|
| Corporate name | STEM CELLS KYRON COLOMBIA SCKC |
| Location | Cali, Colombia |
| Responsible Medical Director | Dr. Carlos Rojas, MD, CEO |
| Provider services | Fracture and Sports Injury Clinic |
| Supplier laboratory | TRUSTEM BANK SC |
| Clinical contact | Daniel Sanz |
Frequently Asked Questions About Stem Cell Therapy for Herniated Disc
How much does stem cell therapy for a herniated disc cost in Colombia?
The package starts from USD 10,000. The final treatment cost depends on the patient's approved protocol, required medical evaluation, cellular product, administration route, targeted spinal levels, observation requirements, and any additional medical services.
What is included in the USD 10,000 starting price?
The package may include medical-record review, consultation, eligibility assessment, protocol-specific testing, information about the cellular product, treatment administration, clinical monitoring, discharge documentation, medical instructions, and scheduled remote follow-up. Travel and non-medical expenses are not included unless specifically stated in the patient's package.
Can stem cell therapy cure a herniated disc?
No specific cure or outcome can be guaranteed. Stem cell therapy does not mechanically remove a herniated disc or decompress a compressed nerve root. The treatment is an investigational regenerative medicine approach that may be considered for selected patients following medical review.
Who may be eligible for stem cell therapy for a herniated disc?
Eligibility depends on the relationship between the patient's symptoms, neurological findings, MRI results, previous treatment, medical stability, and overall clinical condition. Patients should also have realistic expectations and be able to follow rehabilitation and follow-up recommendations.
What type of stem cells are used?
The package uses umbilical cord-derived mesenchymal stem cells. The treatment protocol determines the final dose, targeted spinal levels, and administration plan.
Where are the stem cells administered?
The package describes administration targeting affected facet joints and intervertebral discs according to the patient's medical evaluation and approved protocol.
How long should I stay in Cali?
The suggested stay is approximately 4 days. The exact duration depends on the treatment plan, administration route, clinical response, local observation, neurological status, and medical clearance to travel.
What medical records should I provide before traveling?
Patients should provide relevant medical history, medication information, previous treatment records, and a recent lumbar MRI with the original images and formal report. Additional imaging or medical testing may be reviewed when clinically indicated.
What medications should I stop before treatment?
Patients should not independently stop pain medication, anticoagulants, antiplatelet medications, supplements, or other prescribed treatments. Medication changes should only be made according to medical instructions.
What are the risks of the procedure?
Potential risks include pain, bleeding, infection, inflammatory reactions, allergic or immunological reactions, spinal puncture complications, neurological injury, hematoma, disc or spinal infection, lack of benefit, and other complications associated with the cellular product or administration procedure. Individual risks should be discussed before treatment.
What happens if I develop a problem after returning home?
Patients should follow the post-treatment contact and follow-up plan provided by the medical team and seek appropriate local medical care when necessary. Treatment documentation can also be shared with the patient's healthcare providers at home.
Does participation in clinical research mean the treatment is proven?
No. Clinical research or trial registration does not by itself establish that a treatment has been proven effective for every patient. The investigational nature of the treatment should be understood before making a treatment decision.
Should I get a second opinion before treatment?
An independent medical opinion can help patients review their diagnosis, treatment alternatives, potential risks, travel considerations, and follow-up requirements before proceeding with an investigational intervention.
Take the Next Step Toward Better Mobility
If symptoms from a herniated disc are affecting your mobility, comfort, sleep, work, or everyday activities, an individualized medical review can help determine whether this regenerative medicine option may be appropriate for your condition.
The Stem Cell Therapy for Herniated Disc package in Cali, Colombia includes evaluation of your medical history, MRI findings, previous treatments, clinical eligibility, and proposed treatment approach.
Through PlacidWay Medical Tourism, you can request information about the treatment process, estimated package cost, medical evaluation, suggested stay in Cali, potential eligibility, and follow-up requirements.
Get a Free Quote

Share this listing